# Non-Disclosure Agreement (NDA) Template

## WebQX™ Healthcare Platform Contributor NDA

**CONFIDENTIAL INFORMATION AND NON-DISCLOSURE AGREEMENT**

This Non-Disclosure Agreement ("Agreement") is entered into on ____________ ("Effective Date") between:

**DISCLOSING PARTY:**
- Name: WebQX Health  
- Address: ________________________________  
- Email: ________________________________  

**RECEIVING PARTY:**
- Name: ________________________________  
- Title/Organization: ________________________________  
- Address: ________________________________  
- Email: ________________________________  

---

## 1. PURPOSE AND SCOPE

This Agreement governs the disclosure of confidential information in connection with:
- [ ] WebQX™ platform development and contribution
- [ ] Healthcare workflow design and implementation  
- [ ] Clinical specialty module development
- [ ] Integration with healthcare systems and APIs
- [ ] Research collaboration
- [ ] Other: ________________________________

## 2. DEFINITION OF CONFIDENTIAL INFORMATION

"Confidential Information" includes, but is not limited to:

### 2.1 Technical Information
- Source code, algorithms, and software architectures
- System designs, workflows, and implementation plans
- API specifications and integration methods
- Database schemas and data models
- Security protocols and compliance frameworks
- Performance metrics and analytics

### 2.2 Healthcare-Related Information
- Clinical workflows and specialty-specific processes
- Patient data handling procedures (even if de-identified)
- Healthcare provider integration methods
- Compliance frameworks and audit procedures
- Medical terminology and clinical decision support logic

### 2.3 Business Information
- Strategic plans and roadmaps
- Partnership agreements and vendor relationships
- Financial information and funding details
- Market research and competitive analysis
- User research and healthcare provider feedback

### 2.4 Excluded Information
Confidential Information does NOT include information that:
- Is or becomes publicly available through no breach of this Agreement
- Was rightfully known by Receiving Party prior to disclosure
- Is independently developed by Receiving Party without use of Confidential Information
- Is rightfully received from a third party without restriction

## 3. OBLIGATIONS OF RECEIVING PARTY

The Receiving Party agrees to:

### 3.1 Confidentiality
- Hold all Confidential Information in strict confidence
- Not disclose Confidential Information to any third party without prior written consent
- Use Confidential Information solely for the stated purpose
- Apply the same degree of care as used for own confidential information (minimum: reasonable care)

### 3.2 Access Limitation
- Limit access to Confidential Information to employees, contractors, or advisors who:
  - Have a legitimate need to know
  - Have been informed of the confidential nature
  - Are bound by confidentiality obligations at least as restrictive as this Agreement

### 3.3 Security Measures
- Implement appropriate technical and organizational security measures
- Follow HIPAA-level security standards for healthcare-related information
- Report any suspected or actual breach of confidentiality immediately
- Maintain audit logs of access to Confidential Information where technically feasible

## 4. SPECIAL HEALTHCARE CONSIDERATIONS

### 4.1 HIPAA Compliance
- Even though this project involves healthcare technology, no actual PHI (Protected Health Information) should be shared under this NDA
- Any inadvertent disclosure of PHI must be reported immediately
- Synthetic or test data used must be clearly marked as such

### 4.2 Clinical Safety
- Any safety-related concerns discovered in the platform must be disclosed promptly
- Clinical workflow discussions must maintain focus on software implementation rather than patient care advice

### 4.3 Regulatory Considerations
- Both parties acknowledge that healthcare software may be subject to FDA or other regulatory oversight
- Confidential Information may include regulatory strategies and compliance approaches

## 5. INTELLECTUAL PROPERTY

### 5.1 No License Grant
- This Agreement does not grant any license or rights to intellectual property
- All intellectual property rights remain with the Disclosing Party
- Separate agreements may be required for contribution of derivative works

### 5.2 Contributor Rights
- Contributions to open-source components remain subject to the Apache 2.0 license
- See separate IP Addendum ([`ip-addendum.md`](./ip-addendum.md)) for detailed IP assignment terms

## 6. TERM AND TERMINATION

### 6.1 Duration
This Agreement shall remain in effect for:
- [ ] _____ years from the Effective Date
- [ ] Until terminated by either party with _____ days written notice
- [x] Indefinitely, until terminated by either party with 30 days written notice

### 6.2 Survival
- Confidentiality obligations survive termination for 5 years
- Healthcare-related confidentiality obligations survive indefinitely
- Return/destruction obligations take effect immediately upon termination

### 6.3 Return of Information
Upon termination or request, Receiving Party shall:
- Return or destroy all Confidential Information
- Certify in writing that all copies have been returned or destroyed
- Continue to maintain confidentiality of any retained information

## 7. REMEDIES AND ENFORCEMENT

### 7.1 Injunctive Relief
- Breach may cause irreparable harm for which monetary damages are inadequate
- Disclosing Party may seek injunctive relief without posting bond
- This does not limit other available legal remedies

### 7.2 Monetary Damages
- Receiving Party may be liable for actual damages caused by breach
- In healthcare contexts, damages may include regulatory penalties and patient safety costs

## 8. GENERAL PROVISIONS

### 8.1 Governing Law
This Agreement shall be governed by the laws of ____________ without regard to conflict of law principles.

### 8.2 Jurisdiction
Any disputes shall be resolved in the courts of ____________.

### 8.3 Entire Agreement
This Agreement constitutes the entire agreement between the parties regarding confidential information and supersedes all prior agreements.

### 8.4 Amendment
This Agreement may only be amended in writing signed by both parties.

### 8.5 Severability
If any provision is found unenforceable, the remainder of the Agreement shall remain in effect.

### 8.6 Counterparts
This Agreement may be executed in counterparts, including electronic signatures.

---

## SIGNATURE BLOCK

**DISCLOSING PARTY:**

WebQX Health

By: ________________________________  
Name: ________________________________  
Title: ________________________________  
Date: ________________________________  

**RECEIVING PARTY:**

By: ________________________________  
Name: ________________________________  
Title: ________________________________  
Date: ________________________________  

---

## EXHIBIT A: SPECIFIC PROJECT DETAILS

**Project Name:** ________________________________

**Expected Duration:** ________________________________

**Key Contact Information:**
- Primary Technical Contact: ________________________________
- Legal/Compliance Contact: ________________________________
- Emergency Contact: ________________________________

**Specific Confidential Information Categories for This Project:**
- [ ] Source code for ________________________________ modules
- [ ] Healthcare workflow for ________________________________ specialty
- [ ] Integration specifications for ________________________________
- [ ] Other: ________________________________

**Special Instructions or Restrictions:**
________________________________
________________________________
________________________________

---

*This template is provided for general informational purposes only and does not constitute legal advice. Parties should consult with qualified legal counsel before using this template, particularly for healthcare-related collaborations that may involve regulatory compliance requirements.*